Evidence map›Paper›PMID 36893200›Full record

ArticlePloS one2023

Prevalence and factors associated with pediatric HIV therapy failure in a tertiary hospital in Asmara, Eritrea: A 15-year retrospective cohort study.

Samuel Tekle Mengistu, Ghirmay Ghebrekidan Ghebremeskel, Oliver Okoth Achila, Miriam Berhane Abrehe, Samuel Fisseha Tewelde, Mahmud Mohammed Idris, Tsegereda Gebrehiwot Tikue, Araia Berhane Mesfin

Abstract read
In one paragraph

Article in PloS one, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Samuel Tekle MengistuNakfa Hospital, Ministry of Health Northern Red Sea Branch, Nakfa, Eritrea.ORCID 0000-0002-2817-1421
Ghirmay Ghebrekidan GhebremeskelNakfa Hospital, Ministry of Health Northern Red Sea Branch, Nakfa, Eritrea.ORCID 0000-0002-0275-2279
Oliver Okoth AchilaDepartment of Allied Health Sciences, Orotta College of Medicine and Health Sciences, Asmara, Eritrea.
Miriam Berhane AbreheDepartment of Pediatrics and Child Health, Orotta National Referral and Teaching Hospital, Asmara, Eritrea.
Samuel Fisseha TeweldeDepartment of Pediatrics and Child Health, Orotta National Referral and Teaching Hospital, Asmara, Eritrea.
Mahmud Mohammed IdrisOrotta School of Medicine, Orotta College of Medicine and Health Sciences, Asmara, Eritrea.ORCID 0000-0002-4159-8155
Tsegereda Gebrehiwot TikueOrotta School of Medicine, Orotta College of Medicine and Health Sciences, Asmara, Eritrea.
Araia Berhane MesfinNational Communicable Disease Control Division, Ministry of Health, Asmara, Eritrea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionTreatment failure (TF) in HIV infected children is a major concern in resource-constrained settings in Sub-Saharan Africa (SSA). This study investigated the prevalence, incidence, and factors associated with first-line cART failure using the virologic (plasma viral load), immunologic and clinical criteria among HIV-infected children.

methodsA retrospective cohort study of children (<18 years of age on treatment for a period of > 6 months) enrolled in the pediatric HIV/AIDs treatment program at Orotta National Pediatric Referral Hospital from January 2005 to December 2020 was conducted. Data were summarized using percentages, medians (± interquartile range (IQR)), or mean ± standard deviation (SD). Where appropriate, Pearson Chi-Squire (χ2) tests or Fishers exacts test, Kaplan-Meier (KM) estimates, and unadjusted and adjusted Cox-proportional hazard regression models were employed.

resultsOut of 724 children with at least 24 weeks' follow-up 279 experienced therapy failure (TF) making prevalence of 38.5% (95% CI 35-42.2) over a median follow-up of 72 months (IQR, 49-112 months), with a crude incidence of failure of 6.5 events per 100- person-years (95% CI 5.8-7.3). In the adjusted Cox proportional hazards model, independent factors of TF were suboptimal adherence (Adjusted Hazard Ratio (aHR) = 2.9, 95% CI 2.2-3.9, p < 0.001), cART backbone other than Zidovudine and Lamivudine (aHR = 1.6, 95% CI 1.1-2.2, p = 0.01), severe immunosuppression (aHR = 1.5, 95% CI 1-2.4, p = 0.04), wasting or weight for height z-score < -2 (aHR = 1.5, 95% CI 1.1-2.1, p = 0.02), late cART initiation calendar years (aHR = 1.15, 95% CI 1.1-1.3, p < 0.001), and older age at cART initiation (aHR = 1.01, 95% CI 1-1.02, p < 0.001).

conclusionsSeven in one hundred children on first-line cART are likely to develop TF every year. To address this problem, access to viral load tests, adherence support, integration nutritional care into the clinic, and research on factors associated with suboptimal adherence should be prioritized.

Indexed as

Anti-HIV AgentsHIV InfectionsChildEritreaHumansInfantPrevalenceRetrospective StudiesTertiary Care CentersAnti-HIV Agents

Identifiers

PMID36893200
PMCPMC9997912

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.